455 related articles for article (PubMed ID: 32723434)
1. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
2. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
3. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
Front Immunol; 2020; 11():584241. PubMed ID: 33178218
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
5. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
6. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
[TBL] [Abstract][Full Text] [Related]
7. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
8. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
9. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
10. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
Oba S; Hosoya T; Kaneshige R; Kawata D; Yamaguchi T; Mitsumura T; Shimada S; Shibata S; Tateishi T; Koike R; Tohda S; Hirakawa A; Yoko N; Otomo Y; Nojima J; Miyazaki Y; Yasuda S
Front Immunol; 2023; 14():1227547. PubMed ID: 37908357
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.
Emmenegger M; Emmenegger V; Shambat SM; Scheier TC; Gomez-Mejia A; Chang CC; Wendel-Garcia PD; Buehler PK; Buettner T; Roggenbuck D; Brugger SD; Frauenknecht KBM
Clin Immunol; 2023 Dec; 257():109845. PubMed ID: 37995947
[TBL] [Abstract][Full Text] [Related]
13. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Persijn L; Decavele AS; Schouwers S; Devreese K
Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
[TBL] [Abstract][Full Text] [Related]
16. Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia.
Bnina AB; Dhia RB; Gnaba S; Annabi A; Chouchane S; Naija W; Said H; Oueslati A; Bouatay A
Pan Afr Med J; 2022; 42():110. PubMed ID: 36034019
[TBL] [Abstract][Full Text] [Related]
17. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
Front Immunol; 2022; 13():953043. PubMed ID: 36189273
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of automated chemiluminescent methods for anticardiolipin and anti-β2-glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndrome.
Wan LY; Gu JY; Liu TT; Hu QY; Jia JC; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Chi HH; Zhou ZC; Wang ZH; Zhou JF; Norman GL; Dai J; Yang CD; Shi H
Int J Lab Hematol; 2020 Apr; 42(2):206-213. PubMed ID: 31958215
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit.
Karahan S; Erol K; Yuksel RC; Artan C; Celik I
Mod Rheumatol; 2022 Jan; 32(1):163-168. PubMed ID: 33620009
[TBL] [Abstract][Full Text] [Related]
20. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.
Zuo Y; Willis R; Papalardo E; Petri M; Harris EN; Schleh A; DeCeulaer K; Smikle M; Vilá LM; Reveille JD; Alarcón GS; Gonzalez EB
Lupus; 2017 May; 26(6):606-615. PubMed ID: 27753626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
